Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.61% |
| 2 | Financials | 4.93% |
| 3 | Healthcare | 4% |
| 4 | Consumer Discretionary | 3.82% |
| 5 | Industrials | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4201
CALL
Alnylam Pharmaceuticals
ALNY
$30.6B
| $2.16M | ﹤0.01% |
29,800
-55,300
| -65% | -$4.24M |
|
4202
BOK Financial
BOKF
$8.88B
| $2.16M | ﹤0.01% |
28,649
+21,648
| +309% | +$1.76M |
|
4203
CALL
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
$2.12B
| $2.16M | ﹤0.01% |
8,680
+3,110
| +56% | +$685K |
|
4204
Vident International Equity Strategy
VIDI
$450M
| $2.16M | ﹤0.01% |
89,405
-6,431
| -7% | -$155K |
|
4205
CALL
Cameco
CCJ
$42.6B
| $2.16M | ﹤0.01% |
201,100
+116,500
| +138% | +$1.25M |
|
4206
PUT
Ligand Pharmaceuticals
LGND
$5.87B
| $2.16M | ﹤0.01% |
30,297
-54,983
| -64% | -$4.05M |
|
4207
CALL
Ares Capital
ARCC
$14.3B
| $2.15M | ﹤0.01% |
120,100
-162,500
| -58% | -$2.88M |
|
4208
AutoZone
AZO
$49.4B
| $2.15M | ﹤0.01% |
1,960
-21,863
| -92% | -$23M |
|
4209
Carlyle Group
CG
$17.6B
| $2.15M | ﹤0.01% |
95,185
+35,359
| +59% | +$728K |
|
4210
iShares Global Financials ETF
IXG
$702M
| $2.15M | ﹤0.01% |
33,570
-31,567
| -48% | -$2.01M |
|
4211
CALL
Fidelity National Financial
FNF
$13.3B
| $2.15M | ﹤0.01% |
55,432
+13,312
| +32% | +$502K |
|
4212
NovoCure
NVCR
$1.97B
| $2.15M | ﹤0.01% |
33,953
-36,238
| -52% | -$1.84M |
|
4213
CALL
CrowdStrike
CRWD
$221B
| $2.14M | ﹤0.01% |
+125,600
| New | +$2.14M |
|
4214
Lindsay Corp
LNN
$1.17B
| $2.14M | ﹤0.01% |
26,075
-2,012
| -7% | -$168K |
|
|
EXTN
4215
DELISTED
Exterran Corporation
EXTN
| $2.14M | ﹤0.01% |
150,786
+6,616
| +5% | +$97K |
|
4216
PUT
Tower Semiconductor
TSEM
$30B
| $2.14M | ﹤0.01% |
135,900
+41,100
| +43% | +$685K |
|
|
NAV
4217
CALL
DELISTED
Navistar International
NAV
| $2.14M | ﹤0.01% |
62,200
-39,100
| -39% | -$1.3M |
|
|
IMMU
4218
PUT
DELISTED
Immunomedics Inc
IMMU
| $2.14M | ﹤0.01% |
154,400
-56,300
| -27% | -$847K |
|
4219
CALL
Levi Strauss
LEVI
$8.68B
| $2.14M | ﹤0.01% |
102,500
+86,800
| +553% | +$1.91M |
|
4220
Shutterstock
SSTK
$210M
| $2.14M | ﹤0.01% |
54,620
-2,204
| -4% | -$91.5K |
|
4221
CALL
Arrowhead Research
ARWR
$12.2B
| $2.14M | ﹤0.01% |
80,600
+21,800
| +37% | +$478K |
|
4222
Mueller Industries
MLI
$14.6B
| $2.14M | ﹤0.01% |
291,904
+35,108
| +14% | +$257K |
|
|
DISCK
4223
PUT
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $2.13M | ﹤0.01% |
75,000
-4,200
| -5% | -$114K |
|
4224
argenx
ARGX
$53.3B
| $2.13M | ﹤0.01% |
15,055
+6,712
| +80% | +$852K |
|
4225
Four Corners Property Trust
FCPT
$2.77B
| $2.13M | ﹤0.01% |
77,934
+58,406
| +299% | +$1.67M |
|
Similar funds
Ken Griffin's Q2 2019 Portfolio in Review
As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
- Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
- Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.